Ads
related to: breast cancer stages survival rates
Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga· 2 days agoThe study evaluated Keytruda in combination with chemotherapy as a pre-operative (neoadjuvant)...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 18 hours agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
Mammography is not banned in Switzerland, suspended in Canada
AFP via Yahoo News· 2 days agoBreast cancer screening recommendations vary across different health systems, but claims that...
SSM Health Medical Minute: Lung cancer screening as critical as mammogram, colonoscopy
KTVI via Yahoo News· 19 hours agoLung cancer is the leading cause for cancer-related death in the United States. Screening before...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes. They might...
The Daily Dot· 3 hours agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Top 10 most common cancers among Blacks
Rolling Out· 1 day agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoKEYTRUDA is an anti-PD-1 therapy and was assessed in combination with chemotherapy...by KEYTRUDA...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 6 days ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 6 days agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A ...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 6 days agoShanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers ...